Skip to main content
Clinical Trials/NCT05951569
NCT05951569
Completed
Not Applicable

An Observational Study of Adults With Type 2 Diabetes Using the Community-Derived Open-Source Automated Insulin Delivery Loop System

Jaeb Center for Health Research1 site in 1 country8 target enrollmentJune 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Jaeb Center for Health Research
Enrollment
8
Locations
1
Primary Endpoint
Measure of Loop Safety by Self-Report of Diabetic Ketoacidosis (DKA) Events
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

An observational study to collect data on the efficacy, safety, usability, and quality of life/psychosocial effects of the community-derived OS-AID Loop System on adults with type 2 diabetes.

Detailed Description

The study will include adults with type 2 diabetes in the United States, with a recruitment goal of a maximum of 100 participants. Data to be collected to address the study objective will include CGM metrics; HbA1c; insulin delivery data; carbohydrate data; activity data from HealthKit; self-reported adverse events (e.g., severe hypoglycemia, diabetic ketoacidosis, hospitalizations); self-reported device issues; and user experience/treatment satisfaction surveys. Follow-up data will be collected on a monthly basis as long as the study is continuing and participants are still using Loop.

Registry
clinicaltrials.gov
Start Date
June 20, 2023
End Date
September 8, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jaeb Center for Health Research
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetes
  • Age ≥18 years old
  • Currently using any version of Loop other than v3.0.0 or planning to start using any version of Loop other than v3.0.0 Loop within the next 30 days
  • Willing and able to provide informed consent and to complete surveys and provide the device data that are part of the protocol
  • Resident of the US
  • English speaking/reading
  • Access to email/phone

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Measure of Loop Safety by Self-Report of Diabetic Ketoacidosis (DKA) Events

Time Frame: Up to 3 months

Number of DKA events and event outcomes. DKA events are defined as hospitalization with documentation of arterial blood pH \<7.30 or venous pH \<7.24 or serum bicarbonate (or CO2) \<15.

Measure of Loop Safety by Self-Report of Severe Hypoglycemic Events

Time Frame: Up to 3 months

Number of severe hypoglycemic events and event outcomes. Severe hypoglycemia is defined as low blood sugar that affected the individual's ability to think such that they were unable to treat themselves and needed assistance from someone else. The individual may or may not have lost consciousness.

Measure of Loop Safety by Self-Report of Hospitalization Events

Time Frame: Up to 3 months

Number of hospitalizations

Study Sites (1)

Loading locations...

Similar Trials